Skip to search formSkip to main contentSkip to account menu

mycophenolic acid glucuronide

Known as: MPAG cpd 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Mycophenolic acid (MPA), the active metabolite of mycophenolate mofetil (MMF) has been introduced into renal transplant… 
Highly Cited
2005
Highly Cited
2005
The authors evaluated the intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid after oral… 
Highly Cited
2004
2003
2003
Mycophenolic acid, the active moiety of mycophenolate mofetil, inhibits the enzyme inosine monophosphate dehydrogenase. The main… 
Highly Cited
2002
Highly Cited
2002
Determinants of the wide interindividual variability of the pharmacokinetics of mycophenolic acid (MPA) in 21 stable pediatric… 
Highly Cited
2001
Highly Cited
2001
AIMS To estimate the relative contribution of liver, kidney and jejunum to MPA elimination via glucuronidation from in vitro… 
Highly Cited
2001
Highly Cited
2001
The pharmacokinetics of mycophenolic acid (MPA) was studied after oral administration of mycophenolate mofetil (MMF) in 8 liver… 
Highly Cited
2001
Highly Cited
2001
The remarkably strong formation of the mycophenolic acid molecular ion from mycophenolic acid glucuronide during electrospray… 
Highly Cited
1997
Highly Cited
1997
Mycophenolic acid glucuronide (MPAG) inhibition kinetics were evaluated using purified recombinant human type II inosine… 
Review
1995
Review
1995
Summary Validated high-performance liquid chromatographic (HPLC) methods have been developed for the reliable measurement in…